Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025MedicineOpen Access

Pathogenic mechanisms and treatment advances in proliferative vitreoretinopathy: A review

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJinhui DaiXZXiaorong ZhouHBHaixia Bai

Discussion

Loading...

Member takes

Overview

Review highlights pathogenesis and treatment strategies for proliferative vitreoretinopathy, indicating surgical risks.

Key Points

  • Proliferative vitreoretinopathy is a leading cause of treatment failure in retinal detachment.
  • Current surgical approaches involve membrane removal, but recurrence rates post-surgery remain a concern.
  • The understanding of PVR's pathogenesis is complex, with no ideal therapeutic options established yet.
  • This review explores various treatment strategies and their implications for managing proliferative vitreoretinopathy.

Cite This Study

Dai et al. (2025) studied this question.

synapsesocial.com/papers/68dd91dafe798ba2fc4991bbhttps://doi.org/10.1097/md.0000000000044804
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.1989 · 483 citations
  2. 2CD82 attenuates TGF-β1-mediated epithelial-mesenchymal transition by blocking smad-dependent signaling in ARPE-19 cells2022 · 10 citations
  3. 3Non-viral gene therapy using RNA interference with PDGFR-α mediated epithelial-mesenchymal transformation for proliferative vitreoretinopathy2023 · 6 citations
  4. 4Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid2004 · 138 citations
  5. 5TGF-β1 Induced Transdifferentiation of RPE Cells is Mediated by TAK12015 · 61 citations